Enzo Biochem, Inc. (Farmingdale, NY...
Enzo Biochem, Inc. (Farmingdale, NY) reports Phase I clinical trial inferences of its Crohn's Disease treatment, a network of autologous colon-specific antigens. Ten make subordinates with mild-to-moderate Crohn's Disease were admitted to the trial and were treated with the application of mind drug. The drug was administered orally three times a week for 16 weeks. All 10 make subordinates ...
|